# A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

> **NCT01940133** · PHASE1 · COMPLETED · sponsor: **PIQUR Therapeutics AG** · enrollment: 28 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** PQR309

## Key facts

- **NCT ID:** NCT01940133
- **Lead sponsor:** PIQUR Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01940133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01940133, "A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01940133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*